Mobile

Cyclophosphamide and dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenolidomide and bortezo...

Mise à jour : Il y a 5 ans
Référence : ISRCTN58227268

Cyclophosphamide and dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenolidomide and bortezomib

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-cyclophosphamide-dexamethasone-and-ixazomib-for-myeloma-muk-8

Critère d'inclusion

  • Topic: Cancer; Subtopic: Haematological Oncology; Disease: Myeloma

Liens